Syquant Capital Sas has filed its 13F form on October 28, 2025 for Q3 2025 where it was disclosed a total value porftolio of $348 Million distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Verona Pharma PLC with a value of $129M, Kellogg CO with a value of $124M, 89bio, Inc. with a value of $38.1M, Interpublic Group Of Companies, Inc. with a value of $23.8M, and Informatica Inc. with a value of $13.4M.

Examining the 13F form we can see an increase of $46.8M in the current position value, from $302M to 348M.

Below you can find more details about Syquant Capital Sas portfolio as well as his latest detailed transactions.

Portfolio value $348 Million
Healthcare: $168 Million
Consumer Defensive: $124 Million
Communication Services: $23.8 Million
Technology: $13.4 Million
Basic Materials: $2.86 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $348 Million
  • Prior Value $302 Million
  • Filing
  • Period Q3 2025
  • Filing Date October 28, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 13 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Syquant Capital Sas Portfolio

Follow Syquant Capital Sas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syquant Capital Sas, based on Form 13F filings with the SEC.

News

Stay updated on Syquant Capital Sas with notifications on news.